Education
About Us
Working with TipRanks
Follow Us
Bausch + Lomb Corporation (BLCO)
NYSE:BLCO
BLCO Analyst Ratings
Hold
3 Buy
6 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
BLCO Stock 12 Month Forecast
Average Price Target
$14.50
▲(6.30% Upside)
| Highest Price Target$17.00 | Average Price Target$14.50 | Lowest Price Target$12.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$14
Hold
2.64%
Upside
Reiterated
08/09/25
Bausch + Lomb's overall stock score reflects a mixed outlook. The most significant factor is the company's financial performance, which is under pressure due to profitability challenges. However, positive earnings call updates and strategic financial moves provide some optimism. Technical indicators and valuation remain less favorable, indicating a cautious approach is warranted.
Barclays
$16
Hold
17.30%
Upside
Reiterated
08/04/25
Bank of America Securities
$13
Sell
-4.69%
Downside
Reiterated
08/04/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (NYSE: BLCO), Avantor (NYSE: AVTR) and AptarGroup (NYSE: ATR)We still believe that investor interest will be limited until there is more visibility on the separation. We reiterate our Underperform. We raise our PO to $13 (from $11) based on 10x 2026 EV/EBITDA (9x previously) as a solid 1H drives a slightly higher multiple. Contact lens market appears to have rebounded in Q2 BLCO contact lens growth was +6.8% an acceleration from a tougher comp. Both BLCO and JNJ saw Q2 growth accelerate over Q1 on tougher comps. We think this suggests that the contact lens market likely bounced back in Q2 but need to wait for to report later this month.
RBC Capital
$17
Buy
24.63%
Upside
Reiterated
07/31/25
H.C. Wainwright
$15→$16
Buy
17.30%
Upside
Reiterated
07/31/25
J.P. Morgan
$13
Hold
-4.69%
Downside
Reiterated
07/30/25
Needham
―
Hold
―
Reiterated
07/30/25
Stifel Nicolaus
$12
Hold
-12.02%
Downside
Reiterated
07/10/25
Citi
$13→$15
Hold
9.97%
Upside
Reiterated
07/07/25
Wells Fargo
$12
Hold
-12.02%
Downside
Reiterated
07/02/25
Morgan Stanley
$19→$18
Hold
31.96%
Upside
Reiterated
02/25/25
Raymond James
$23→$22
Buy
61.29%
Upside
Reiterated
02/20/25
Jefferies
$25
Buy
83.28%
Upside
Reiterated
12/12/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$14
Hold
2.64%
Upside
Reiterated
08/09/25
Bausch + Lomb's overall stock score reflects a mixed outlook. The most significant factor is the company's financial performance, which is under pressure due to profitability challenges. However, positive earnings call updates and strategic financial moves provide some optimism. Technical indicators and valuation remain less favorable, indicating a cautious approach is warranted.
Barclays
$16
Hold
17.30%
Upside
Reiterated
08/04/25
Bank of America Securities
$13
Sell
-4.69%
Downside
Reiterated
08/04/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (NYSE: BLCO), Avantor (NYSE: AVTR) and AptarGroup (NYSE: ATR)We still believe that investor interest will be limited until there is more visibility on the separation. We reiterate our Underperform. We raise our PO to $13 (from $11) based on 10x 2026 EV/EBITDA (9x previously) as a solid 1H drives a slightly higher multiple. Contact lens market appears to have rebounded in Q2 BLCO contact lens growth was +6.8% an acceleration from a tougher comp. Both BLCO and JNJ saw Q2 growth accelerate over Q1 on tougher comps. We think this suggests that the contact lens market likely bounced back in Q2 but need to wait for to report later this month.
RBC Capital
$17
Buy
24.63%
Upside
Reiterated
07/31/25
H.C. Wainwright
$15→$16
Buy
17.30%
Upside
Reiterated
07/31/25
J.P. Morgan
$13
Hold
-4.69%
Downside
Reiterated
07/30/25
Needham
―
Hold
―
Reiterated
07/30/25
Stifel Nicolaus
$12
Hold
-12.02%
Downside
Reiterated
07/10/25
Citi
$13→$15
Hold
9.97%
Upside
Reiterated
07/07/25
Wells Fargo
$12
Hold
-12.02%
Downside
Reiterated
07/02/25
Morgan Stanley
$19→$18
Hold
31.96%
Upside
Reiterated
02/25/25
Raymond James
$23→$22
Buy
61.29%
Upside
Reiterated
02/20/25
Jefferies
$25
Buy
83.28%
Upside
Reiterated
12/12/24
Best Analysts Covering Bausch + Lomb Corporation
1 Month
xxx
Success Rate
6/12 ratings generated profit
Average Return
-1.13%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -1.13% per trade.
3 Months
xxx
Success Rate
12/23 ratings generated profit
Average Return
+1.47%
reiterated a xxx
rating 11 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 52.17% of your transactions generating a profit, with an average return of +1.47% per trade.
1 Year
Success Rate
9/12 ratings generated profit
Average Return
+7.45%
reiterated a sell rating 7 days ago
Copying Craig Bijou's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +7.45% per trade.
2 Years
xxx
Success Rate
8/12 ratings generated profit
Average Return
+6.98%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +6.98% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
BLCO Analyst Recommendation Trends
Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
0
0
0
0
0
Buy
6
4
3
7
5
Hold
15
12
15
15
15
Sell
2
2
1
1
1
Strong Sell
0
0
0
0
0
total
23
18
19
23
21
Each month's total comprises the sum of three months' worth of ratings.
BLCO Financial Forecast
BLCO Stock Forecast FAQ
What is BLCO’s average 12-month price target, according to analysts?
Based on analyst ratings, Bausch + Lomb Corporation’s 12-month average price target is 14.50.
What is BLCO’s upside potential, based on the analysts’ average price target?
Bausch + Lomb Corporation has 6.30% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BLCO a Buy, Sell or Hold?
Bausch + Lomb Corporation has a consensus rating of Hold which is based on 3 buy ratings, 6 hold ratings and 1 sell ratings.
What is Bausch + Lomb Corporation’s price target?
The average price target for Bausch + Lomb Corporation is 14.50. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $17.00 ,the lowest forecast is $12.00. The average price target represents 6.30% Increase from the current price of $13.64.
The highest analyst price target is $17.00 ,the lowest forecast is $12.00. The average price target represents 6.30% Increase from the current price of $13.64.
What do analysts say about Bausch + Lomb Corporation?
Bausch + Lomb Corporation’s analyst rating consensus is a Hold. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of BLCO?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.